The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODOWorld's 1st trial of drug developed from iPS cells to begin
KYOTO©2025 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODO
4 Comments
Login to comment
nakanoguy01
why start with rare diseases? fop hardly seems like a disease that warrants such important research.
gokai_wo_maneku
@nakanoguy04 Not to the people who have it.